Kolexia
Bourreille Arnaud Gastro-entérologie
Bourreille Arnaud
Gastro-entérologie
Hôpital Hôtel-Dieu Nantes
Nantes, France
173 Activités
63 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Rectocolite hémorragique Colite Ulcère Inflammation Maladies intestinales Maladie chronique Sténose pathologique

Collaborateurs

Voir plus
Laharie David
Laharie David
Hôpital Haut-lévêque, Pessac, France
Peyrin-Biroulet Laurent
Peyrin-Biroulet Laurent
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Roblin Xavier
Roblin Xavier
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Bouhnik Yoram
Bouhnik Yoram
Cmc Ambroise Pare Hartmann Site 25, Neuilly-sur-Seine, France

Industries

Voir plus
Janssen
46 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
37 collaboration(s)
Dernière en 2023
Abbvie
34 collaboration(s)
Dernière en 2023
Ferring
12 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Role of ICAM-1 in the Adhesion of T cells to Enteric Glia: Perspectives in the Formation of Plexitis in Crohn's disease.
Cellular and molecular gastroenterology and hepatology   28 février 2024
23 ans ensemble
Edimark   01 décembre 2023
EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis : A Double Blinded Randomized Clinical Trial
Essai Clinique (CHU Rennes)   20 novembre 2023
The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics.
Frontiers in immunology   28 août 2023
Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID.
Clinical and translational gastroenterology   01 août 2023
POCA: Prospective Multicenter Randomized Controlled Double-blind Label Study of the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis
Essai Clinique (CHU Nantes)   14 juin 2023
Myeloid cell influx into the colonic epithelium is associated with disease severity and non-response to anti-Tumor Necrosis Factor Therapy in patients with Ulcerative Colitis.
bioRxiv : the preprint server for biology   05 juin 2023
SPACIFIX: Comparison of Trough Level-based Spacing and Clinical-based Spacing of Infliximab Infusions in Patients With Inflammatory Bowel Disease in Deep Remission; A Prospective, Multicenter, Open-label, Randomized, Controlled Study
Essai Clinique (CHU Montpellier)   02 mai 2023
Sacral neuromodulation for refractory ulcerative colitis: safety and efficacy in a prospective observational series of eight patients.
Techniques in coloproctology   12 avril 2023
Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study.
Inflammatory bowel diseases   05 avril 2023